MA43978A - Dérivé de sulfonamide hétérocyclique et médicament le contenant - Google Patents
Dérivé de sulfonamide hétérocyclique et médicament le contenantInfo
- Publication number
- MA43978A MA43978A MA043978A MA43978A MA43978A MA 43978 A MA43978 A MA 43978A MA 043978 A MA043978 A MA 043978A MA 43978 A MA43978 A MA 43978A MA 43978 A MA43978 A MA 43978A
- Authority
- MA
- Morocco
- Prior art keywords
- product containing
- medicinal product
- sulfonamide derivative
- heterocyclic sulfonamide
- heterocyclic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2016021358 | 2016-02-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA43978A true MA43978A (fr) | 2018-12-12 |
Family
ID=59499709
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA043978A MA43978A (fr) | 2016-02-05 | 2017-02-03 | Dérivé de sulfonamide hétérocyclique et médicament le contenant |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US10584116B2 (fr) |
| EP (1) | EP3412664B1 (fr) |
| JP (1) | JP6906449B2 (fr) |
| KR (1) | KR20180104150A (fr) |
| CN (1) | CN108602807B (fr) |
| AU (1) | AU2017213993B2 (fr) |
| BR (1) | BR112018015851A2 (fr) |
| CA (1) | CA3012812A1 (fr) |
| DK (1) | DK3412664T3 (fr) |
| EA (1) | EA037264B1 (fr) |
| ES (1) | ES2911416T3 (fr) |
| MA (1) | MA43978A (fr) |
| MX (1) | MX2018009458A (fr) |
| PL (1) | PL3412664T3 (fr) |
| WO (1) | WO2017135462A1 (fr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3487853B1 (fr) * | 2016-07-20 | 2022-06-08 | F. Hoffmann-La Roche AG | Composés de proline bicycliques |
| FR3114235A1 (fr) | 2020-09-18 | 2022-03-25 | Université Grenoble Alpes | Inhibition du canal trpa1 astrocytaire comme nouvelle cible therapeutique neuroprotectrice dans les phases prodromales de la maladie d’alzheimer |
| IT202100015098A1 (it) | 2021-06-09 | 2022-12-09 | Flonext S R L | Composto antagonista del canale trpa1 per uso in patologie degenerative della retina |
| WO2023033097A1 (fr) * | 2021-09-02 | 2023-03-09 | Ｅａファーマ株式会社 | Procédé de production d'un dérivé de sulfonamide hétérocyclique et intermédiaire synthétique de celui-ci |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8017612B2 (en) * | 2006-04-18 | 2011-09-13 | Japan Tobacco Inc. | Piperazine compound and use thereof as a HCV polymerase inhibitor |
| WO2010141805A1 (fr) * | 2009-06-05 | 2010-12-09 | Janssen Pharmaceutica Nv | Amides hétérocycliques en tant que modulateurs de la trpa1 |
| EP2520566A1 (fr) * | 2011-05-06 | 2012-11-07 | Orion Corporation | Nouveaux composés pharmaceutiques |
| JP6182072B2 (ja) | 2012-01-17 | 2017-08-16 | Ｅａファーマ株式会社 | 複素環アミド誘導体及びそれを含有する医薬 |
| EP2900642B1 (fr) * | 2012-09-27 | 2018-02-28 | F. Hoffmann-La Roche AG | Composés de sulfonamide substitués |
| EP2937335A4 (fr) | 2012-12-18 | 2016-09-14 | Ea Pharma Co Ltd | Dérivé d'amide hétérocyclique et médicament le contenant |
| EP2774919A1 (fr) * | 2013-03-06 | 2014-09-10 | Pharmeste S.R.L. In Liquidazione | Nouveaux antagonistes des récepteurs TRPA1 de sulfonamide |
| ES2713323T3 (es) | 2013-10-11 | 2019-05-21 | Hoffmann La Roche | Compuestos de sulfonamida heterocíclicos sustituidos útiles como moduladores de trpa1 |
| KR20160135183A (ko) | 2014-01-28 | 2016-11-25 | 이에이 파마 가부시키가이샤 | 복소환 술폰아미드 유도체 및 그것을 함유하는 의약 |
| BR112017017052A2 (pt) * | 2015-02-15 | 2018-04-10 | F. Hoffmann-La Roche Ag | derivados de 1-(het)arilsulfonil-(pirrolidina ou piperidina)-2-carboxamida e seu uso como antagonistas de trpa1 |
| EP3330266A1 (fr) * | 2015-07-29 | 2018-06-06 | Ea Pharma Co., Ltd. | Dérivé cyclopropane et médicament le contenant |
-
2017
- 2017-02-03 CA CA3012812A patent/CA3012812A1/fr active Pending
- 2017-02-03 KR KR1020187025206A patent/KR20180104150A/ko not_active Application Discontinuation
- 2017-02-03 EP EP17747613.2A patent/EP3412664B1/fr active Active
- 2017-02-03 WO PCT/JP2017/004134 patent/WO2017135462A1/fr active Application Filing
- 2017-02-03 AU AU2017213993A patent/AU2017213993B2/en active Active
- 2017-02-03 CN CN201780009998.3A patent/CN108602807B/zh active Active
- 2017-02-03 DK DK17747613.2T patent/DK3412664T3/da active
- 2017-02-03 EA EA201891782A patent/EA037264B1/ru unknown
- 2017-02-03 MX MX2018009458A patent/MX2018009458A/es unknown
- 2017-02-03 PL PL17747613T patent/PL3412664T3/pl unknown
- 2017-02-03 BR BR112018015851-8A patent/BR112018015851A2/pt active Search and Examination
- 2017-02-03 ES ES17747613T patent/ES2911416T3/es active Active
- 2017-02-03 MA MA043978A patent/MA43978A/fr unknown
- 2017-02-03 JP JP2017565677A patent/JP6906449B2/ja active Active
-
2018
- 2018-08-03 US US16/054,077 patent/US10584116B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP3412664A1 (fr) | 2018-12-12 |
| EA037264B1 (ru) | 2021-03-01 |
| DK3412664T3 (da) | 2022-06-07 |
| EP3412664A4 (fr) | 2019-10-16 |
| BR112018015851A2 (pt) | 2018-12-26 |
| ES2911416T3 (es) | 2022-05-19 |
| JPWO2017135462A1 (ja) | 2018-12-13 |
| EA201891782A1 (ru) | 2019-06-28 |
| CA3012812A1 (fr) | 2017-08-10 |
| PL3412664T3 (pl) | 2022-06-06 |
| CN108602807B (zh) | 2022-05-13 |
| AU2017213993A1 (en) | 2018-09-13 |
| EP3412664B1 (fr) | 2022-03-30 |
| MX2018009458A (es) | 2018-09-21 |
| US20190023699A1 (en) | 2019-01-24 |
| CN108602807A (zh) | 2018-09-28 |
| AU2017213993B2 (en) | 2021-03-25 |
| KR20180104150A (ko) | 2018-09-19 |
| US10584116B2 (en) | 2020-03-10 |
| JP6906449B2 (ja) | 2021-07-21 |
| WO2017135462A1 (fr) | 2017-08-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA49715A (fr) | Oligomères et conjugués d'oligomères | |
| DK3412660T3 (da) | Sulfonamidderivat og farmaceutisk sammensætning indeholdende samme | |
| DK3532029T3 (da) | Flydende farmaceutisk sammensætning | |
| MA46867A (fr) | Formulations pharmaceutiques | |
| EP3101015A4 (fr) | Dérivé de sulfonamide hétérocyclique et médicament le contenant | |
| DK3255042T3 (da) | Heterocyklisk forbindelse og farmaceutisk sammensætning omfattende samme | |
| DK3634377T3 (da) | Farmaceutisk formulering | |
| MA43705A (fr) | Formulation pharmaceutique | |
| ES2841649T5 (es) | Composición farmacéutica | |
| MA44987A (fr) | Formulations de médicaments améliorées | |
| MA45187A (fr) | Combinaisons pharmaceutiques | |
| MA43978A (fr) | Dérivé de sulfonamide hétérocyclique et médicament le contenant | |
| CL2019000563S1 (es) | Envase y dispendio de medicamentos. (divisional solicitud 201800718) | |
| MA40524A (fr) | Dérivés d'adrénomédulline stabilisés et leur utilisation | |
| DK3426681T3 (da) | Åbne hla-b57-konformere | |
| DK3601277T3 (da) | Farmaceutisk formulering | |
| MA45457A (fr) | Médicament ophtalmique contenant du salbutamol. | |
| DK3453390T3 (da) | Farmaceutisk sammensætning indeholdende polymeriseret lægemiddel | |
| MA46642A (fr) | Promédicaments d'inhibiteurs de la kallicréine | |
| ES1146009Y (es) | Máquina desemblistadora de pastillas y similares | |
| EP3134392A4 (fr) | Dérivés de sulfonamide et leurs applications pharmaceutiques | |
| DK3153163T3 (da) | Farmaceutisk forbindelse der omfatter 13 glycerider, formulering og anvendelse deraf | |
| IL279928A (en) | History of heterocyclic sulfonamides and their pharmaceutical uses | |
| UA37078S (uk) | Розгортка упаковки фармацевтичного засобу | |
| CL2017002185S1 (es) | Tableta farmacéutica |